Location History:
- Fujisawa, JP (2012 - 2013)
- Osaka, JP (2011 - 2014)
- Kanagawa, JP (2016 - 2021)
Company Filing History:
12 out of 1,179 
2 out of 10 Years Active: 2011-2021
Title: Terufumi Takagi: Innovating Cardiac Disease Treatments
Introduction
Terufumi Takagi, an accomplished inventor based in Kanagawa, Japan, holds 14 patents that showcase his significant contributions to pharmaceutical innovations. His work primarily focuses on developing new treatments for cardiac diseases, establishing him as a prominent figure in medical research and invention.
Latest Patents
Among his latest patents is a revolutionary compound designed for the treatment of cardiac diseases. This invention provides a compound exhibiting CaMKII inhibitory action, which has the potential to be an effective agent for preventing and treating conditions such as catecholaminergic polymorphic ventricular tachycardia, postoperative atrial fibrillation, heart failure, and fatal arrhythmias. The innovation details a compound represented by a specific formula, emphasizing its unique properties.
Another notable patent from Takagi is a heterocyclic amide compound that may possess PRS inhibitory action. This compound is anticipated to serve as a prophylactic or therapeutic agent for diseases associated with PRS, including various forms of cancer. This invention also includes a detailed formula representation to convey its intended use.
Career Highlights
Terufumi Takagi has worked with esteemed companies such as Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals, LLC. His tenure in these organizations has provided him with invaluable experience and has positioned him to make significant advancements in cardiac health solutions.
Collaborations
Throughout his career, Takagi has collaborated with notable peers, including Masanori Okaniwa and Atsushi Hasuoka. These partnerships have not only fostered innovative ideas but have also contributed to the successful development of groundbreaking therapeutic agents.
Conclusion
In summary, Terufumi Takagi is an influential inventor whose work is paving the way for advancements in the treatment of cardiac diseases. With a portfolio of 14 patents, he continues to make significant strides in pharmaceuticals, demonstrating the profound impact of innovation in medical science. His contributions will undoubtedly play a critical role in improving patient outcomes in the field of cardiology.